The entity with the most to gain from hospital price transparency is not the patient, not the insurer, and not the regulator. It is the large employer who self-insures and pays claims directly.
Approximately sixty percent of American workers with employer-sponsored insurance are in self-funded plans governed by ERISA. These employers do not pay premiums to an insurer; they pay claims directly, with an insurance company serving only as a third-party administrator. The TPA’s job, nominally, is to negotiate hospital contracts on the employer’s behalf. Whether it does so aggressively is a question that, until recently, employers had almost no way to evaluate.
The TPA relationship has been a persistent source of misaligned incentives in commercial insurance markets. TPAs typically negotiate contracts that apply across their entire book of business, not specifically for any individual employer client. An employer paying claims at rates negotiated for a large, heterogeneous group of employers has no way to know whether its specific utilization patterns—its geography, its employee demographics, its high-cost procedure concentration—warranted different terms. It is structurally unable to evaluate its TPA’s performance.
Price transparency data shifts this, modestly but meaningfully. An employer whose TPA administers a Blue Cross contract can now compare the rates embedded in that contract—reflected in the hospital’s published negotiated rate file—against the rates other employers in the same market are apparently receiving. If the comparison reveals that the employer’s effective rates are at the high end of the market distribution, that is information with direct negotiating value.
The most sophisticated employers have been moving in this direction for some time. Walmart’s direct contracting arrangements with the Mayo Clinic and other Centers of Excellence predate price transparency mandates by years. But Walmart’s approach requires scale and administrative infrastructure that most self-insured employers lack. MedPricer democratizes, if imperfectly, the analytical baseline that has historically required either Walmart-level resources or a health benefits consulting firm with deep market expertise.
The practical application is not, primarily, about employers negotiating their own contracts—most lack the scale to do so unilaterally, outside the narrow direct contracting market. It is about employers using rate data to evaluate TPA performance, select among competing TPAs, or advocate for more aggressive negotiating positions within existing TPA relationships. That is a meaningful shift from the pre-transparency baseline of essentially no employer-side information.
The second application is network design. Employers who can identify, using MedPricer data, which hospitals in their geography have materially lower negotiated rates for high-volume procedures—joint replacements, cardiac procedures, imaging—can use that information to design tiered networks that steer employees toward lower-cost facilities. This is not new as a concept; many large insurers offer tiered networks. What is new is that employers can independently evaluate whether the insurer’s tier assignments reflect actual rate differences or reflect other considerations—like the insurer’s overall relationship with a dominant hospital system.
The counter-dynamic is worth noting. Hospitals that have invested heavily in patient experience, reputation, and brand have genuine leverage against employer-driven tiering. Employees often resist being steered away from a hospital they trust, and employers are politically reluctant to force that choice. Rate-based tiering has consistently underperformed projections for behavior change. The data creates an analytical opportunity; the behavioral economics of employer-sponsored insurance severely constrain its translation into practice.
What MedPricer enables, at minimum, is a more honest conversation between employers, TPAs, and hospital systems about what rates are defensible in a given market. That conversation has been asymmetric for decades. The asymmetry is narrowing.
